Back to Search Start Over

Usage of EpiFinder clinical decision support in the assessment of epilepsy

Authors :
Amy Z. Crepeau
Lidia Csernak
Joseph I Sirven
Neel Mehta
Robert Yao
Matthew T. Hoerth
Erin M. Okazaki
Katherine H. Noe
Joseph F. Drazkowski
Edgar Salinas
Source :
Epilepsy & Behavior. 82:140-143
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

Background The diagnosis of epilepsy is at times elusive for both neurologists and nonneurologists, resulting in delays in diagnosis and therapy. The development of screening methods has been identified as a priority in response to this diagnostic and therapeutic gap. EpiFinder is a novel clinical decision support tool designed to enhance the process of information gathering and integration of patient/proxy respondent data. It is designed specifically to take key terms from a patient's history and incorporate them into a heuristic algorithm that dynamically produces differential diagnoses of epilepsy syndromes. Objective The objective of this study was to test the usability and diagnostic accuracy of the clinical decision support application EpiFinder in an adult population. Methods Fifty-seven patients were prospectively identified upon admission to the Epilepsy Monitoring Unit (EMU) for episode classification from January through June of 2017. Based on semiologic input, the application generates a list of epilepsy syndromes. The EpiFinder-generated diagnosis for each subject was compared to the final diagnosis obtained via continuous video electroencephalogram (cVEEG) monitoring. Results Fifty-three patients had habitual events recorded during their EMU stay. A diagnosis of epilepsy was confirmed (with cVEEG monitoring) in 26 patients while 27 patients were found to have a diagnosis other than epilepsy. The algorithm appropriately predicted differentiation between the presence of an epilepsy syndrome and an alternative diagnosis with 86.8% (46/53 participants) accuracy. EpiFinder correctly identified the presence of epilepsy with a sensitivity of 86.4% (95% confidence interval [CI]: 65.0–97.1) and specificity of 85.1% (95% CI: 70.2–96.4). Conclusion The initial testing of the EpiFinder algorithm suggests possible utility in differentiating between an epilepsy syndrome and an alternative diagnosis in adult patients.

Details

ISSN :
15255050
Volume :
82
Database :
OpenAIRE
Journal :
Epilepsy & Behavior
Accession number :
edsair.doi.dedup.....09404c9b0f6d3f75c6d078abaa486c5c
Full Text :
https://doi.org/10.1016/j.yebeh.2018.03.018